Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 2077-2081

  Marchetti, Antonio ^a   Bertacca, Gloria ^b   Buttitta, Fiamma ^b   Chella, Antonio ^b   Quattrocolo, Gianluca ^b   Angeletti, Carlo Alberto ^b   Bevilacqua, Generoso ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CORRELATION FUNCTION; HIGH RISK PATIENT; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL RATE; TELOMERASE;

EID: 0032766423     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Nesbitt, J. C., Putnam, J. B., Walsh, G. L., Roth, J. A., and Mountain, C. F. Survival in early-stage non-small cell lung cancer. Ann. Thorac. Surg., 60: 466-472, 1995.
2. Strauss, G. M., Kwiatkawski, D. J., Harpole, D. H., Lynch, T. J., Skarin, A. T., and Sugarbaker, D. J. Molecular and pathologic markers in stage I non-small cell carcinoma of the lung. J. Clin. Oncol., 13: 1265-1279, 1995.
3. Greider, C. W., and Blackburn, E. H. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell, 43: 405-413, 1985.
4. Morin, G. B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59: 521-529, 1989.
5. Royle, N. J. Telomeres and disease. J. Pathol., 180: 233-235, 1996.
6. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M, Wright, W. E, Weinrich, S. L, and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
7. Piatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright W. E., and Shay, J. W. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci., 17: 1-15, 1995.
8. Shay, J. W., and Wright, W. E. Telomerase activity in human cancer. Curr. Opin. Oncol., 8: 66-71, 1996.
9. Tahara, J., Nakanishi, T., Kitamoto, M., Nakashio, R., Shay, J. W., Tahara, E., Kajiyama, G., and Ide, T. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res., 55: 2734-2736, 1995.
10. Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., and Shay PJ. Telomerase activity in human breast tumors. J. Natl. Cancer Inst., 88: 116-122, 1996.
11. Ohyashiki, K., Ohyashiki, J. K., Iwama, H., Hayashi, S., Shay, J. W, and Toyama, K. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia (Baltimore), 11: 190-194, 1997.
12. Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., and Shay, J. W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med., 1: 249-255, 1995.
13. Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., and Murakami, Y. Telomerase activity in gastric cancer. Cancer Res., 55: 3258-3262, 1995.
14. Kim, N. W., Levitt, D., Huang, G., Wu, F., Osborne, K., and Clark, G. Correlation of telomerase with prognostic indicators of breast cancer. Proc. Am. Assoc. Cancer Res., 37: 561-562, 1996.
15. Clark, G. M., Osborne, C. K., Levitt, D., Wu, F., and Kim, N. W. Telomerase activity and survival of patients with node-positive breast cancer. J. Natl. Cancer Inst., 89: 1874-1881, 1997.
16. Breslow, R. A., Shay, J. W., Gazdar, A. F., and Srivastava, S. Telomerase and early detection of cancer. J. Natl. Cancer Inst., 89: 618-623, 1997.
17. Mehle, C., Piatyszek, M. A., Ljungberg, B., Shay, J. W., and Roos, G. Telomerase activity in human renal cell carcinoma. Oncogene, 13: 161-166, 1996.
18. Albanell, J., Leonardo, F., Rusch, V., Engelhardt, M., Langenfeld, J., Han, W., Klimstra, D., Venkatraman, E., Moore, M. A. S., and Dmitrovsky E. High telomerase activity in primary lung cancer: association with increased cell proliferation rates and advanced pathologic stage. J. Natl. Cancer Inst., 89: 1609-1615, 1997.
19. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., and Shay, J. W. Telomerase activity in small-cell and non-small-cell lung cancer. J. Natl. Cancer Inst., 87: 895-902, 1995.
20. Mountain, C. F. A new international staging system for lung cancer. Chest, 89 (Suppl.): 225S-233S, 1986.
21. Kaplan, E. L., and Meir, P. L. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
22. Cox, D. R., and Oakes, D. Analysis of Survival Data. New York: Chapman and Hall, 1984.
23. Cox, D. R. Regression models and life-tables. J. R. Stat. Soc., 34: 187-200, 1972.
24. WHO. The World Health Organization. Histological typing of lung tumors. Am. J. Clin. Pathol., 77: 123-136, 1982.
25. Smith, E. F., Groen, J. M., Splinter, T. A. W., Ebels, T., and Postmus, P. E. New prognostic factors in resectable non-small cell lung cancer. Thorax, 51: 638-646, 1996.
26. Mountain, C. F. New prognostic factors in lung cancer: biologic prophets of cancer cell aggression. Chest, 108: 246-254, 1995.
27. Van Zandwijk, N., Mooi, W. J., and Rodenhuis, S. Prognostic factors in NSCLC: recent experiences. Lung Cancer (Limerick), 12: 527-533, 1995.
28. Hiraga, S., Ohnishi, T., Izumoto, S., Miyahara, E., Kanemura, Y., Matsumura, H., and Arita, N. Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res., 58: 2117-2125, 1998.
29. Shroyer, K. R., Thompson, L. C., Enomoto, T., Eskens, J. L, Shroyer, A. L., and McGregor, J. A. Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix. Am. J. Clin. Pathol., 109: 153-162, 1998.
30. Kannan, S., Tahara, H., Yokozaki, H., Mathew, B., Nalinakumari, K. R., Nair, M. K., and Tahara, E. Telomerase activity in premalignant and malignant lesions of human oral mucosa. Cancer Epidemiol. Biomark. Prev., 6: 413-420, 1997.
31. Ahn, M. J., Noh, Y. H., Lee, Y. S., Lee, J. H., Chung, T. J., Kim, I. S., Choi, I. Y, Kim, S. H., Lee, J. S., and Lee, K. H. Telomerase activity and its clinicopathologic significance in gastric cancer. Eur. J. Cancer, 33: 1309-1313, 1997.
32. Shroyer, K. R., Stephens, J. K., Silverberg, S. G., Markham, N., Shroyer, A. L., Wilson, M. L., and Enomoto, T. Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma. Int. J. Gynecol. Pathol., 16: 225-232, 1997.
33. Mehle, C., Piatyszek, M. A, Ljungberg, B., Shay, J. W., and Roos, G. Telomerase activity in human renal cell carcinoma. Oncogene, 13: 161-166, 1996.